FLOW by Race and Ethnicity: Semaglutide's Kidney and Heart Benefits Looked Similar Across Groups

A post hoc FLOW analysis found no statistical evidence that semaglutide 1.0 mg weekly worked differently by race or ethnicity on four outcomes. Only 160 participants were Black, so the analysis cannot rule out meaningful differences.

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.